Description
EO 14398
Base award description: RADIOPHARMACEUTICALS
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-10-01+$1,000,000= $1,000,000
- Mod P000012023-10-01+$1,000,000= $2,000,000
- Mod P000022024-06-20-$508,670= $1,491,330
- Mod P000032024-10-01+$1,100,000= $2,591,330
- Mod P000042025-08-27-$516,446= $2,074,885
- Mod P000052025-09-22+$0= $2,074,885
- Mod P000062025-10-01+$1,150,000= $3,224,885
- Mod P000072026-03-23-$509,128= $2,715,757
- Mod P000082026-06-05+$0= $2,715,757
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-10-01 | +$1,000,000 | $1,000,000 | RADIOPHARMACEUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-10-01 | +$1,000,000 | $2,000,000 | RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2024-06-20 | −$508,670 | $1,491,330 | RADIOPHARMACEUTICALS |
| Mod P00003· EXERCISE AN OPTION | 2024-10-01 | +$1,100,000 | $2,591,330 | RADIOPHARMACEUTICALS EXERCISE OPTION |
| Mod P00004· FUNDING ONLY ACTION | 2025-08-27 | −$516,446 | $2,074,885 | RADIOPHARMACEUTICALS EXERCISE OPTION |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2025-09-22 | +$0 | $2,074,885 | RADIOPHARMACEUTICALS EXERCISE OPTION |
| Mod P00006· EXERCISE AN OPTION | 2025-10-01 | +$1,150,000 | $3,224,885 | RADIOPHARMACEUTICALS EXERCISE OPTION |
| Mod P00007· FUNDING ONLY ACTION | 2026-03-23 | −$509,128 | $2,715,757 | DEOBLIGATE FUNDING FOR OPTION PERIOD. RADIOPHARMACEUTICALS EXERCISE OPTION |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2026-06-05 | +$0 | $2,715,757 | EO 14398 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24526N0840 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $19,139 | FY2026 |
| 36C24526N0839 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $38,360 | FY2026 |
| 36C24526N0837 | QOL MEDICAL LLC | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $16,945 | FY2026 |
| 36C24526N0835 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $34,605 | FY2026 |
| 36C24526N0834 | GALDERMA LABORATORIES, L.P. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $16,960 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24523P0041_3600_-NONE-_-NONE- · retrieved 2026-09-26.